Breadcrumb Home Yale Technologies Intron Therapeutics: Targeting the Unique Features of Fungal Metabolism to Build a New Generation of Nontoxic Drugs The Blavatnik Fund for Innovation at Yale Showcase 09/17/2020 Intron Therapeutics: Targeting the Unique Features of Fungal Metabolism to Build a New Generation of Nontoxic Drugs Investigators Anna M. Pyle, Ph.D. Sterling Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry; Director, Division of Biological Sciences
Anna M. Pyle, Ph.D. Sterling Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry; Director, Division of Biological Sciences
